DuPont has inaugurated a new probiotics fermentation unit at its facility in Rochester, New York, as part of a $100 million investment to expand its probiotics capacity.
The facility is now producing probiotics for the dietary supplement and food and beverage industries.
DuPont said the unit features an automated system of sensors and monitors that helps maintain optimal growing conditions, removing the need to take traditional manual samples. It also has bacteria freezing technology for safe storage of the probiotics.
“The investment in our Rochester probiotics operation furthers our strategy to provide health and nutrition science solutions to this growing market,” said DuPont CEO Marc Doyle.
In addition to the company’s capital investment, construction of the fermentation unit was supported by a grant provided by Empire State Development.
“We deeply appreciate the support from the state of New York as we launch this industry-leading endeavour,” said Matthias Heinzel, president of DuPont Nutrition & Biosciences.
“We’re proud to be part of the Rochester community and to expand our footprint at the Eastman Business Park. This investment represents our deep commitment to driving innovation through probiotic research and manufacturing.”
In 2016, DuPont said it would invest around $100 million to expand its probiotics production capacity in the US.
In May, the company announced the creation of DuPont Nutrition & Biosciences, which combines its Nutrition & Health and Industrial Biosciences divisions into one unit.
© FoodBev Media Ltd 2024
